Dr. Anjali Deshmukh is an Assistant Professor of Law at Seton Hall University Law School and a board-certified pediatrician. Her research lies at the intersection of FDA regulation and administrative law. It focuses on the effects of pharmaceutical law and regulatory policy on patient health outcomes, with particular attention to children. Her work integrates quantitative empirical methods with normative and doctrinal analysis to examine judicial review and the regulation of emerging technologies, including cell and gene therapies, regenerative medicine, and artificial intelligence.
